EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The active components and potential mechanisms of Li-Chong-Xiao-Zhen granules in the treatment of ovarian cancer: An integrated metabolomics, proteomics, network pharmacology and experimental validation

Yiliu Chen, Ran Su, Yunguang Hu, Jiali Luo, Chu Yi, Yinbin Zhu, Qing Feng, Xianxin Yan, Min Ma, Weifeng Feng

Journal of Ethnopharmacology · 2025

DOI: 10.1016/j.jep.2025.119474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Yiliu Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Jinan University, 510632, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Drugs, Chinese Herbal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Fundamental Research Funds for the Central Universities, Traditional Chinese Medicine Bureau of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Li-Chong-Xiao-Zhen granules (LCXZG) has the effect of " activate blood and resolve stasis," " soften hardness and dissipate binds " properties, and was widely used in the clinic for decades to treat uterine fibroids and ovarian cancer (OC), which is called "zheng jia" in traditional Chinese medicine. AIM OF THE STUDY: The aim of this study is to identify the active components of LCXZG and elucidate the mechanism of LCXZG in ovarian cancer by combining network pharmacology, metabolomics and proteomics. MATERIAL AND METHODS: The absorbed compounds in serum of LCXZG was identified by liquid chromatography-mass spectrometry. Network pharmacology was used to predict the active components and target genes of LCXZG. The therapy mechanism of LCXZG on OC were determined by establishing a nude mouse xenograft tumor model and using combined metabolomics and proteomics analysis. RESULTS: A total of 218 absorbed compounds in serum of LCXZG were identified by UPLC-MS. Network pharmacology results showed that lipid and atherosclerosis, chemical carcinoma-receptor activation and PI3K-AKT signaling were potential target pathways of LCXZG in the treatment of OC. Further metabolomics and proteomics studies demonstrated that LCXZG altered glycerophospholipid metabolism in ovarian cancer. CONCLUSIONS: This study demonstrated that most of the active Compound of LCXZG are Paeoniflorin, Turanose, Amygdalin and Benzoylpaeoniflorin, which may exert their anti-tumor effects by regulating glycerophospholipid metabolism in ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsDrugs, Chinese HerbalFemaleAnimalsMetabolomicsHumansNetwork PharmacologyProteomicsMice, NudeMiceCell Line, TumorXenograft Model Antitumor AssaysMice, Inbred BALB C

Stichwörter der Autor:innen

Li-chong-xiao-zhen granulesNon-target metabolomicsOvarian cancerSerum pharmacologyTMT-ProteomicsTraditional Chinese medicine

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • School of Traditional Chinese Medicine, Jinan University, 510632, Guangzhou, Guangdong, China.
  • Guangdong Yi-fang Pharmaceutical Co. Ltd, Jinan University, 528200, Foshan, Guangdong, China.
  • The First Affiliated Hospital of Jinan University, 510632, Guangzhou, Guangdong, China. Electronic address: fwf2000ok@jnu.edu.cn.

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Fundamental Research Funds for the Central Universities
  • Traditional Chinese Medicine Bureau of Guangdong Province
  • Guangzhou Municipal Science and Technology Project
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Chen, Y., Su, R., Hu, Y., Luo, J., Yi, C., Zhu, Y., Feng, Q., Yan, X., Ma, M., & Feng, W. (2025). The active components and potential mechanisms of Li-Chong-Xiao-Zhen granules in the treatment of ovarian cancer: An integrated metabolomics, proteomics, network pharmacology and experimental validation. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119474

Vancouver

Chen Y, Su R, Hu Y, Luo J, Yi C, Zhu Y, et al. The active components and potential mechanisms of Li-Chong-Xiao-Zhen granules in the treatment of ovarian cancer: An integrated metabolomics, proteomics, network pharmacology and experimental validation. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119474

BibTeX
@article{Chen2025,
  author = {Chen, Yiliu and Su, Ran and Hu, Yunguang and Luo, Jiali and Yi, Chu and Zhu, Yinbin and Feng, Qing and Yan, Xianxin and Ma, Min and Feng, Weifeng},
  title = {The active components and potential mechanisms of Li-Chong-Xiao-Zhen granules in the treatment of ovarian cancer: An integrated metabolomics, proteomics, network pharmacology and experimental validation},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  doi = {10.1016/j.jep.2025.119474}
}
Kostenlos starten →